Englewood Lab Inc (950140) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Englewood Lab Inc (950140) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.76 Billion ≈ $4.58 Million USD) by net assets (₩154.89 Billion ≈ $104.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Englewood Lab Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Englewood Lab Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Englewood Lab Inc (950140) financial obligations for a breakdown of total debt and financial obligations.
Englewood Lab Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Englewood Lab Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Financiera Independencia S.A.B. de C.V. SOFOM E.N.R
MX:FINDEP
|
0.097x |
|
Tiziana Life Sciences Ltd
NASDAQ:TLSA
|
-0.742x |
|
FutureFuel Corp
NYSE:FF
|
-0.007x |
|
SK D&D Co Ltd
KO:210980
|
-0.133x |
|
Mnc Investama Tbk
JK:BHIT
|
0.006x |
|
INFOM
KLSE:0265
|
0.062x |
|
Landmark Bancorp Inc
NASDAQ:LARK
|
0.064x |
|
Motonic
KO:009680
|
0.016x |
Annual Cash Flow Conversion Efficiency for Englewood Lab Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Englewood Lab Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Englewood Lab Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩97.89 Million ≈ $66.34K |
₩9.47 Million ≈ $6.42K |
0.097x | -46.14% |
| 2023-12-31 | ₩89.12 Million ≈ $60.40K |
₩16.01 Million ≈ $10.85K |
0.180x | -99.86% |
| 2022-12-31 | ₩73.41 Million ≈ $49.75K |
₩9.56 Billion ≈ $6.48 Million |
130.256x | +229.58% |
| 2021-12-31 | ₩68.28 Million ≈ $46.28K |
₩-6.86 Billion ≈ $-4.65 Million |
-100.526x | -176.80% |
| 2020-12-31 | ₩55.76 Million ≈ $37.79K |
₩7.30 Billion ≈ $4.95 Million |
130.892x | -42.97% |
| 2019-12-31 | ₩52.79 Million ≈ $35.78K |
₩12.12 Billion ≈ $8.21 Million |
229.494x | +224.24% |
| 2018-12-31 | ₩50.72 Million ≈ $34.37K |
₩-9.37 Billion ≈ $-6.35 Million |
-184.721x | -15.82% |
| 2017-12-31 | ₩56.31 Million ≈ $38.16K |
₩-8.98 Billion ≈ $-6.09 Million |
-159.487x | -340171.13% |
| 2016-12-31 | ₩61.90 Million ≈ $41.95K |
₩-2.90 Million ≈ $-1.97K |
-0.047x | -10.74% |
| 2015-12-31 | ₩26.65 Billion ≈ $18.06 Million |
₩-1.13 Billion ≈ $-764.48K |
-0.042x | -- |
About Englewood Lab Inc
Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; a… Read more